期刊文献+

桑夏扶正汤剂联合雾化治疗小儿病毒性肺炎的临床效果及安全性评价 被引量:19

Clinical Effect and Safety Evaluation of Sangxia Fuzheng Decoction Combined with Atomization in the Treatment of Viral Pneumonia in Children
下载PDF
导出
摘要 目的探讨桑夏扶正汤剂联合雾化治疗小儿病毒性肺炎的临床效果及安全性。方法选取2018年1月—2019年1月治疗的病毒性肺炎患儿150例,按照治疗方法分为联用组与西药组。联用组给予桑夏扶正汤剂联合雾化治疗,西药组给予奥司他韦联合利巴韦林治疗。比较2组治疗前后血清降钙素原(PCT)、C反应蛋白(CRP)水平;观察2组治疗后肺炎严重度评分(PSI)等级、临床症状消失时间、血氧饱和度、呼吸频率以及总不良反应发生率。结果与治疗前比较,治疗后各时间段2组的血清PCT和CRP水平明显降低(P<0.05)。治疗后2、7、14 d,联用组血清PCT和CRP水平明显低于西药组(P<0.05)。治疗后,联用组血氧饱和度、呼吸频率、PSI评分等级、临床症状消失时间及总不良反应发生率明显优于西药组(P<0.05)。结论桑夏扶正汤剂联合雾化治疗小儿病毒性肺炎,可以在祛除病邪的同时,兼顾调整机体阴阳、免疫平衡,有效减轻病毒性肺炎的炎症反应,提高患儿疗效,且不良反应发生率少,安全性高。 Objective To explore the clinical effect and safety of Sangxia Fuzheng decoction combined with atomization in the treatment of viral pneumonia in children.Methods From January 2018 to January 2019,150 children with viral pneumonia were selected and divided into two groups according to the treatment method:combination group and western medicine group.The combination group was given Sangxia Fuzheng decoction combined with atomization treatment,while the western medicine group was given Oseltamivir combined with Ribavirin treatment.Before and after treatment,the levels of serum procalcitonin(PCT)and C-reactive protein(CRP)were compared.The pneumonia severity index(PSI),the disappearance time of clinical symptoms,blood oxygen saturation,respiratory rate and the total incidence of adverse reactions were observed.Results Compared with those before treatment,the levels of serum PCT and CRP in the two groups at different time periods were significantly lower after treatment(P<0.05).At 2,7 and 14 days after treatment,the levels of serum PCT and CRP in the combination group were significantly lower than those in the western medicine group(P<0.05).After treatment,blood oxygen saturation,respiratory rate,PSI score,disappearance time of clinical symptoms and total incidence of adverse reactions in the combination group were significantly better than those in the western medicine group(P<0.05).Conclusion The combination of Sangxia Fuzheng decoction and atomization in the treatment of viral pneumonia in children can not only eliminate pathogenic factors,but also adjust the balance of Yin and Yang and immunity.In addition,it can effectively reduce the inflammatory reaction of viral pneumonia,and improve the curative effect on children,with lower incidence of adverse effects and better safety.
作者 刘媛 范中娥 范方勇 范中欣 马国妹 郑丽 代树栋 LIU Yuan;FAN Zhong-e;FAN Fang-yong;FAN Zhong-xin;MA Guo-mei;ZHENG Li;DAI Shu-dong(Department of Pediatrics,Huanghua people's Hospital,Huanghua,Hebei 061100,China;Department of Obstetrics and Gynecology,Huanghua Maternal and Child Health and Family Planning Service Center,Huanghua,Hebei 061100,China;Department of Otolaryngology,Boai Hospital,Huanghua Development Zone,Huanghua,Hebei 061100,China)
出处 《解放军医药杂志》 CAS 2020年第6期56-59,共4页 Medical & Pharmaceutical Journal of Chinese People’s Liberation Army
基金 河北省中医药管理局科研计划项目(2019311)。
关键词 肺炎 病毒性 雾化 桑夏扶正汤剂 儿童 C反应蛋白 降钙素原 Pneumonia viral Atomization Sangxia fuzheng decoction Child C-reactive protein Procalcitonin
  • 相关文献

参考文献10

二级参考文献111

  • 1何义平,费军,余洪俊,黄显凯,梁华平,蒋耀光.严重多发伤患者血清降钙素原与ARDS关系研究[J].创伤外科杂志,2006,8(3):231-233. 被引量:12
  • 2陈志,林明贵,梁建琴,王金河.活动性肺结核患者血清炎性因子变化特点及与免疫状态的关系[J].第三军医大学学报,2006,28(11):1234-1236. 被引量:12
  • 3胡凤华,甘小庄,孙丽萍,任晓旭,郭琳英.儿童肺炎支原体肺炎血清中降钙素原的含量及其临床意义[J].中国小儿急救医学,2006,13(3):234-235. 被引量:8
  • 4阿斯木古丽.克力木,古丽巴哈尔.卡,努尔曼古丽,巴哈尔,热比亚.被动吸烟对7~12岁儿童肺活量的影响[J].中国学校卫生,2006,27(8):704-705. 被引量:6
  • 5左启华.儿科学[M].3版.北京:人民卫生出版社,1993:452.
  • 6Lee CC, Chen SY, Tsai CL, et al. Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-re- active protein in patients with sepsis at the emergency department [ J ]. Shock,2008,29 ( 3 ) : 322 - 327.
  • 7Muller F, Christ-Crain M, Bregenzer T, et al. Procalcitonin lev- els predict bacteremia in patients with community-acquired pneu- monia : a prospective cohort trial[ J ]. Chest, 2010,138 ( 1 ) : 121 - 129.
  • 8van Nieuwkoop C, Bonten TN, van' t Want JW, et al. Procalci- tonin reflects bacteremia and bacterial load in urosepsis syn- drome : a prospective observational study [ J ]. Crit Care, 2010, 14(6) :206.
  • 9Oberhoffer M, Stonauus I, Russwurm S, et al. Procaleitonin ex- pression in human peripheral blood mononuelear cells and its modulation by Hpopolysaeeharides and sepsis-inbred cytokines in vitro[J]. J Lab Clin Med,1999,134( 1 ) :49 -55.
  • 10Meisner M, Lohs T, Huettemann E, et al. The plasma elimination rate and urinary secretion of procaleitonin in patients with normal and impaired renal function [ J ]. Eur J Anaesthesiol, 2001,18 (2):70 -87.

共引文献71

同被引文献202

引证文献19

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部